ArticleFrontiers in oncology2021

Durable Response to Immunotherapy With Antiangiogenic Drug in Large-Cell Lung Carcinoma With Multiple Fulminant Postoperative Metastases: A Case Report.

Zhilin Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.